Macro Briefing | 1 July 2020
FDA Sets Bar for COVID-19 Vaccine Approval at 50 Percent Effectiveness
COVID-19: Study shows virus can infect heart cells in lab dish
Designing anew: Radical COVID-19 drug development approach shows promise
Face mask construction, materials matter for containing coughing, sneezing droplets
Inovio Presents ‘Positive’ Early Data For Covid-19 Vaccine Candidate; Shares Plunge 12%
Salk researchers accelerate, expand COVID-19 research
HKUST sets up a platform of vaccine target recommendations for COVID-19
MLB Trade Rumors and News: Four players have opted out of the 2020 season so far
The US isn't in a second wave of coronavirus – the first wave never ended
COVID-19 messes with Texas: What went wrong, and what other states can learn as younger people get sick
New Flu Virus With "Pandemic Potential" Emerges In China
Bharat Biotech begins trial of COVID-19 vaccine in India as cases mount
WHO ACT-Accelerator prioritizes global vaccine approach
Coronavirus: the antibody drugs few people have been discussing – until now
Vaxart Oral COVID-19 Vaccine Joins Trump’s “Warp Speed,” Ramps Up Manufacturing Capacity
3 "Strong Buy" Coronavirus Stocks With Massive Upside Potential
COVID-19 messes with Texas: What went wrong and how the state can turn it around
Guest Contribution: “Covid-induced precautionary saving in the US: the role of unemployment rate”
Gilead Sets Pricing For Remdesivir Vaccine At $2,340 Per Patient
Novavax Stock Is on Its Way to Break Through the $100 Mark, Says 5-Star Analyst
Even in the worst COVID-19 cases, the body launches immune cells to fight back
NUS research team develops portable COVID-19 diagnostic system for rapid on-site testing
Mass-Tracking COVI-PASS Immunity Passports To Be Rolled Out In 15 Countries
AstraZeneca Strikes $127 Million Deal With Brazil For Covid-19 Vaccine
Morgan Stanley: Yes, A Second Wave Is Coming But It Won't Derail The V-Shaped Recovery
Global coronavirus cases exceed 10 million
Plagued Retail: A View From The Trenches
"Disturbing Parallel To HIV": COVID-19 Can Cause Depletion Of Important Immune Cells, NY Times Admits
Six Downside Risks